• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News
Friday, March 31, 2023
  • Login
Country First
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
Country First
No Result
View All Result

Cord Blood transplant outperforms bone marrow transplant states a new study by ASH

Country First by Country First
March 31, 2021
in Health & Fitness
Reading Time: 3 mins read
A A
0
Share on FacebookShare on Twitter
  • Published in the journal – Blood Advances – the studies aim to study the efficacy of cord blood in treatment of diverse disorders

  • Studies’ outcome crucial for multi-ethnic country like India, where the chances of finding a matching donor are very low.

New Delhi: American Society of Hematology (ASH), the world’s largest professional society working to conquer blood diseases has recently released two key studies on cord blood transplants, as part of its Blood Advances journal. Led by a team of leading researchers from University of Colorado and University of Pittsburgh, the two studies have brought to foray the various benefits of cord blood transplant over bone marrow in cancerous and non-cancerous disorders. With the growing concerns among medical fraternity about finding matching bone marrow donors in a multi-ethnic country like India, the findings of the studies clearly outline the efficacy of cord blood in the treatment of diverse disorders.

In the study conducted to weigh benefits of cord blood transplant over bone marrow transplant for cancerous disorders, University of Colorado researchers compared the outcomes of matched bone marrow and double-unit cord blood transplants in adults. Amongst the 313 patients studied (190 cord blood transplant and 123 matched related donor transplant patients), the two key findings emerged. One, Chances of developing graft versus host disease were higher with bone marrow as compared to cord blood transplants and two, it was discovered that relapse rates were lower in patients who received a cord blood transplant.

You might also like

Japan-based Toyota Tsusho Corporation and Tokai Corp Partner to Launch Valabhi Hospital Services

Japan-based Toyota Tsusho Corporation and Tokai Corp Partner to Launch Valabhi Hospital Services

March 20, 2023
Do rare Diseases account for the economic burden on India?

Do rare Diseases account for the economic burden on India?

March 20, 2023

Followed by the findings of the first study, a second study on the efficacy of cord blood transplant among non-cancerous disorders was also undertaken by a team of researchers from University of Pittsburgh. The researchers successfully treated 44 children suffering from various non-cancerous & immune disorders with a combination of low dose chemotherapy and single-unit of HLA-mismatched cord blood with no cell expansion. The successful outcomes provided by this first of its kind and the largest trial showed that cord blood outperformed bone marrow in terms of graft failure, treatment related mortality and event-free survival. Also, this gives tremendous confidence to patients & doctors in a multi-ethnic country like India where the chances of finding a matching donor are very low.

Commenting on this, Dr. Sunil Bhat, MBBS, MD (Pediatrics) Mazumdar Shaw Cancer Centre, Narayana Health City, Bengaluru said, “Authors have tried a new conditioning regimen which is “reduced toxicity” hence less toxic to the patients but at the same time quite effective resulting into good outcomes in these difficult disease conditions. The application of “immune boost” post-transplant is also novel and results into better immune recovery and less complications especially of infections post cord blood transplant.”

“Another study which was published during same year gives a clear understanding on how to select a cord blood donor based on Human Leukocyte Antigens (HLA) match and also makes clear recommendations on the stem cell dose required for successful transplant. This study is also a great guide to the physicians to select cord blood donors for transplant purpose.

Other key highlights from the studies:

Study 1 – To understand the efficacy of Cord Blood transplants over bone marrow for Cancerous disorders

  • Outcomes of this study demonstrated that cancer patients undergoing cord blood transplants showed better improvement & developed lesser complications than those who received matched sibling donor transplants.
  • The overall improved recovery rate and lack of complications resulted in low costs associated with post-transplant care.
  • This treatment protocol had a distinct positive impact on the patients’ quality of life.

 

Study 2 – To understand the efficacy of Cord Blood transplants over bone marrow for non-cancerous disorders

  • The graft failure rate of <5% seen in this trial is the lowest ever reported for non-manipulated cord blood grafts in non-cancerous or even in cancerous diseases.
  • The lowest 1-year (Treatment-Related Mortality) TRM of 5%, resulting in >90% Event Free Survival (EFS) at 1 year was reported.
  • A single unit of allogeneic cord blood could be identified for each of the 44 eligible children regardless of their ethnicities, showing the unique and unparalleled suitability of cord blood grafts even without being perfectly (HLA) matched.
  • No cell expansion was required in the trial. In general, a single cord blood unit doesn’t have sufficient stem cells to treat adults.
  • No patient developed severe chronic graft versus host disease and a distinct improvement in the quality of life was reported.
  • The novel treatment protocol used in the trial prevented graft failure and aided immune reconstitution.
Previous Post

SBI Foundation to help deploy two indigenous innovations for COVID care

Next Post

New hope for mitochondrial disorders

Country First

Country First

Related Posts

Japan-based Toyota Tsusho Corporation and Tokai Corp Partner to Launch Valabhi Hospital Services

Japan-based Toyota Tsusho Corporation and Tokai Corp Partner to Launch Valabhi Hospital Services

by Country First
March 20, 2023
0

To provide End-to-End Linen Management Services in India Bangalore (Karnataka) : Toyota Tsusho, a renowned global trading company within the...

Do rare Diseases account for the economic burden on India?

Do rare Diseases account for the economic burden on India?

by Country First
March 20, 2023
0

The meaning of the term "Rare" is "not occur very often", but rare diseases are cumulatively not so rare anymore....

zPlus.care for all your healthcare needs

zPlus.care for all your healthcare needs

by Country First
March 17, 2023
0

zPlus.Care, where monthly shopping, bill payments pay for your health care. Health insurance should be every Indian’s priority but in...

YOGA - A blessing for feminine fitness by Heena Rajgor

YOGA – A blessing for feminine fitness by Heena Rajgor

by Country First
March 9, 2023
0

Yoga is an effective workout that can be easily practiced from home or anywhere, do not even need any instruments....

Next Post

New hope for mitochondrial disorders

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Post

Akshaya Patra Scales Up its Relief Feeding Efforts in Maharashtra, serves over 47 lakhs meals 

May 26, 2021
Dhrriti Saharan launches her Music Label SOUL TUNES inaugurated by Vidya Malavade in Juhu, Mumbai

Dhrriti Saharan launches her Music Label SOUL TUNES inaugurated by Vidya Malavade in Juhu, Mumbai

March 2, 2023

As Third Wave of COVID-19 rolls out ActionAid Association prepares humanitarian response

January 7, 2022

Category

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Gadgets
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • World

Tags

Ace Entrepreneur Ahmedabad Artificial intelligence Bengaluru Blockchain technology Content Creator COVID-19 Cryptocurrency CSIR DBT DeFi and NFT navigation tool Delhi DeSpace Protocol Digital Marketing disease DST Dubai Education entrepreneur environment Ginny Kapoor Gujarat India's Most Prominent Pageant Indian Institute of Technology Influencer Influencerquipo Kingston Technology MoES Mr. Gagandeep Kapoor Mrs.INDIA Galaxy Mrs.INDIA Galaxy 2022 Mumbai Music Industry National Pageant Mrs.INDIA Galaxy 2022 NFT pandemic photography real estate research science social media Surat technology TTK Prestige Vibrant Concepts

Country First is a digital news and story platform that bring you the news, articles, stories, and opinions on the latest happenings worldwide covering various sectors like nation, politics, and governance, social sector, review, foreign affairs, defence and security, latest review, lifestyle, entertainment, sports, technology, auto sectors, education, business and start-ups updates, Agriculture, Science, finance, money, food, and culture, etc.

  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News

© 2022 Country First

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 Country First

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In